BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32000638)

  • 1. Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway.
    Afshari AR; Mollazadeh H; Mohtashami E; Soltani A; Soukhtanloo M; Hosseini A; Jalili-Nik M; Vahedi MM; Roshan MK; Sahebkar A
    Curr Med Chem; 2021; 28(2):377-400. PubMed ID: 32000638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products as promising targets in glioblastoma multiforme: a focus on NF-κB signaling pathway.
    Soukhtanloo M; Mohtashami E; Maghrouni A; Mollazadeh H; Mousavi SH; Roshan MK; Tabatabaeizadeh SA; Hosseini A; Vahedi MM; Jalili-Nik M; Afshari AR
    Pharmacol Rep; 2020 Apr; 72(2):285-295. PubMed ID: 32152926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.
    Afshari AR; Mollazadeh H; Soukhtanloo M; Hosseini A; Mohtashami E; Jalili-Nik M; Modaresi SMS; Soltani A; Sahebkar A
    Mini Rev Med Chem; 2020; 20(18):1879-1899. PubMed ID: 32767939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme.
    Desai V; Bhushan A
    Biomed Res Int; 2017; 2017():9363040. PubMed ID: 29359162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions.
    Mollazadeh H; Mohtashami E; Mousavi SH; Soukhtanloo M; Vahedi MM; Hosseini A; Afshari AR; Sahebkar A
    Curr Pharm Des; 2020; 26(37):4777-4788. PubMed ID: 32493186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention and therapeutic role of essential oils and phenolic compounds: Modeling tumor microenvironment in glioblastoma.
    Magalhães M; Manadas B; Efferth T; Cabral C
    Pharmacol Res; 2021 Jul; 169():105638. PubMed ID: 33933637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of studies on natural products for glioblastoma therapy.
    Xu F; Yang YH; Yang H; Li W; Hao Y; Zhang S; Zhang YZ; Cao WX; Li XX; Du GH; Ji TF; Wang JH
    J Asian Nat Prod Res; 2024 Jan; 26(1):154-176. PubMed ID: 38321773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
    Altinoz MA; Elmaci İ
    Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis: a novel therapeutic target for glioblastoma.
    Jiang YG; Peng Y; Koussougbo KS
    Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
    Wardak Z; Choe KS
    Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD44 in glioblastoma multiforme.
    Mooney KL; Choy W; Sidhu S; Pelargos P; Bui TT; Voth B; Barnette N; Yang I
    J Clin Neurosci; 2016 Dec; 34():1-5. PubMed ID: 27578526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
    Reardon DA; Wen PY
    Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme.
    Tavana E; Mollazadeh H; Mohtashami E; Modaresi SMS; Hosseini A; Sabri H; Soltani A; Javid H; Afshari AR; Sahebkar A
    Biofactors; 2020 May; 46(3):356-366. PubMed ID: 31880372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
    Raizer JJ
    J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current natural therapies in the treatment against glioblastoma.
    Erices JI; Torres Á; Niechi I; Bernales I; Quezada C
    Phytother Res; 2018 Nov; 32(11):2191-2201. PubMed ID: 30109743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme.
    Tagde P; Tagde P; Tagde S; Bhattacharya T; Garg V; Akter R; Rahman MH; Najda A; Albadrani GM; Sayed AA; Akhtar MF; Saleem A; Altyar AE; Kaushik D; Abdel-Daim MM
    Biomed Pharmacother; 2021 Sep; 141():111928. PubMed ID: 34323701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.
    Pawlowska E; Szczepanska J; Szatkowska M; Blasiak J
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Nitric Oxide in Glioblastoma Therapy: Another Step to Resolve the Terrible Puzzle ?
    Altieri R; Fontanella M; Agnoletti A; Panciani PP; Spena G; Crobeddu E; Pilloni G; Tardivo V; Lanotte M; Zenga F; Ducati A; Garbossa D
    Transl Med UniSa; 2015; 12():54-9. PubMed ID: 26535188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.